The National Breast & Cervical Cancer Early Detection Program
For 30 years, the Centers for Disease Control and Prevention’s National Breast and Cervical Cancer Early Detection Program has decreased disparities in breast and cervical cancer deaths.
Recommendations for FDA's Office of Minority Health and Health Equity (OMHHE)
February 28, 2020
In response to a request from FDA, ACS CAN has provided recommendations for areas of focus for the Office of Minority Health and Health Equity (OMHHE). Recommendations include assessing the applicability of drug "snapshot" data, evaluating the appropriateness of aggregating racial groups for analysis, and examination of drug classes where differences in metabolism, safety or efficacy are likely to be seen.